167 related articles for article (PubMed ID: 27041583)
1. The heparan sulfate sulfotransferase 3-OST3A (HS3ST3A) is a novel tumor regulator and a prognostic marker in breast cancer.
Mao X; Gauche C; Coughtrie MW; Bui C; Gulberti S; Merhi-Soussi F; Ramalanjaona N; Bertin-Jung I; Diot A; Dumas D; De Freitas Caires N; Thompson AM; Bourdon JC; Ouzzine M; Fournel-Gigleux S
Oncogene; 2016 Sep; 35(38):5043-55. PubMed ID: 27041583
[TBL] [Abstract][Full Text] [Related]
2. Epigenetics: methylation-associated repression of heparan sulfate 3-O-sulfotransferase gene expression contributes to the invasive phenotype of H-EMC-SS chondrosarcoma cells.
Bui C; Ouzzine M; Talhaoui I; Sharp S; Prydz K; Coughtrie MW; Fournel-Gigleux S
FASEB J; 2010 Feb; 24(2):436-50. PubMed ID: 19812376
[TBL] [Abstract][Full Text] [Related]
3. Heparan sulfate mediates trastuzumab effect in breast cancer cells.
Suarez ER; Paredes-Gamero EJ; Del Giglio A; Tersariol IL; Nader HB; Pinhal MA
BMC Cancer; 2013 Oct; 13():444. PubMed ID: 24083474
[TBL] [Abstract][Full Text] [Related]
4. HSulf-1 inhibits angiogenesis and tumorigenesis in vivo.
Narita K; Staub J; Chien J; Meyer K; Bauer M; Friedl A; Ramakrishnan S; Shridhar V
Cancer Res; 2006 Jun; 66(12):6025-32. PubMed ID: 16778174
[TBL] [Abstract][Full Text] [Related]
5. The heparan sulfate 3-O-sulfotransferases (HS3ST) 2, 3B and 4 enhance proliferation and survival in breast cancer MDA-MB-231 cells.
Hellec C; Delos M; Carpentier M; Denys A; Allain F
PLoS One; 2018; 13(3):e0194676. PubMed ID: 29547633
[TBL] [Abstract][Full Text] [Related]
6. HS2ST1-dependent signaling pathways determine breast cancer cell viability, matrix interactions, and invasive behavior.
Vijaya Kumar A; Brézillon S; Untereiner V; Sockalingum GD; Kumar Katakam S; Mohamed HT; Kemper B; Greve B; Mohr B; Ibrahim SA; Goycoolea FM; Kiesel L; Pavão MSG; Motta JM; Götte M
Cancer Sci; 2020 Aug; 111(8):2907-2922. PubMed ID: 32573871
[TBL] [Abstract][Full Text] [Related]
7. Ovarian cancer cell heparan sulfate 6-O-sulfotransferases regulate an angiogenic program induced by heparin-binding epidermal growth factor (EGF)-like growth factor/EGF receptor signaling.
Cole CL; Rushton G; Jayson GC; Avizienyte E
J Biol Chem; 2014 Apr; 289(15):10488-10501. PubMed ID: 24563483
[TBL] [Abstract][Full Text] [Related]
8. A synthetic heparan sulfate oligosaccharide library reveals the novel enzymatic action of D-glucosaminyl 3-O-sulfotransferase-3a.
Nguyen TK; Arungundram S; Tran VM; Raman K; Al-Mafraji K; Venot A; Boons GJ; Kuberan B
Mol Biosyst; 2012 Feb; 8(2):609-14. PubMed ID: 22116385
[TBL] [Abstract][Full Text] [Related]
9. CHST11 gene expression and DNA methylation in breast cancer.
Herman D; Leakey TI; Behrens A; Yao-Borengasser A; Cooney CA; Jousheghany F; Phanavanh B; Siegel ER; Safar AM; Korourian S; Kieber-Emmons T; Monzavi-Karbassi B
Int J Oncol; 2015 Mar; 46(3):1243-51. PubMed ID: 25586191
[TBL] [Abstract][Full Text] [Related]
10. The Emerging Roles of Heparan Sulfate 3-
Denys A; Allain F
Front Oncol; 2019; 9():507. PubMed ID: 31249810
[TBL] [Abstract][Full Text] [Related]
11. Changes in heparan sulfate sulfotransferases and cell-surface heparan sulfate during SKM-1 cells granulocytic differentiation and A549 cells epithelial-mesenchymal transition.
Zhao S; Wang Z
Glycoconj J; 2020 Apr; 37(2):151-164. PubMed ID: 31863309
[TBL] [Abstract][Full Text] [Related]
12. The Pro-Tumoral Activity of Heparan Sulfate 3-
Hellec C; Diawara M; Carpentier M; Denys A; Allain F
Molecules; 2018 Oct; 23(10):. PubMed ID: 30360368
[TBL] [Abstract][Full Text] [Related]
13. 2-O Heparan Sulfate Sulfation by Hs2st Is Required for Erk/Mapk Signalling Activation at the Mid-Gestational Mouse Telencephalic Midline.
Chan WK; Howe K; Clegg JM; Guimond SE; Price DJ; Turnbull JE; Pratt T
PLoS One; 2015; 10(6):e0130147. PubMed ID: 26075383
[TBL] [Abstract][Full Text] [Related]
14. A benzimidazole derivative exhibiting antitumor activity blocks EGFR and HER2 activity and upregulates DR5 in breast cancer cells.
Chu B; Liu F; Li L; Ding C; Chen K; Sun Q; Shen Z; Tan Y; Tan C; Jiang Y
Cell Death Dis; 2015 Mar; 6(3):e1686. PubMed ID: 25766325
[TBL] [Abstract][Full Text] [Related]
15. Structural alteration of cell surface heparan sulfate through the stimulation of the signaling pathway for heparan sulfate 6-O-sulfotransferase-1 in mouse fibroblast cells.
Nishida M; Kozakai T; Nagami K; Kanamaru Y; Yabe T
Biosci Biotechnol Biochem; 2014; 78(5):770-9. PubMed ID: 25035978
[TBL] [Abstract][Full Text] [Related]
16. Specific genes involved in synthesis and editing of heparan sulfate proteoglycans show altered expression patterns in breast cancer.
Fernández-Vega I; García O; Crespo A; Castañón S; Menéndez P; Astudillo A; Quirós LM
BMC Cancer; 2013 Jan; 13():24. PubMed ID: 23327652
[TBL] [Abstract][Full Text] [Related]
17. A Her2-let-7-β2-AR circuit affects prognosis in patients with Her2-positive breast cancer.
Liu D; Deng Q; Sun L; Wang T; Yang Z; Chen H; Guo L; Liu Y; Ma Y; Guo N; Shi M
BMC Cancer; 2015 Nov; 15():832. PubMed ID: 26526356
[TBL] [Abstract][Full Text] [Related]
18. Absence of integrin α3β1 promotes the progression of HER2-driven breast cancer in vivo.
Ramovs V; Secades P; Song JY; Thijssen B; Kreft M; Sonnenberg A
Breast Cancer Res; 2019 May; 21(1):63. PubMed ID: 31101121
[TBL] [Abstract][Full Text] [Related]
19. Human Sulfatase 2 inhibits in vivo tumor growth of MDA-MB-231 human breast cancer xenografts.
Peterson SM; Iskenderian A; Cook L; Romashko A; Tobin K; Jones M; Norton A; Gómez-Yafal A; Heartlein MW; Concino MF; Liaw L; Martini PG
BMC Cancer; 2010 Aug; 10():427. PubMed ID: 20707913
[TBL] [Abstract][Full Text] [Related]
20. Endophilin A2 promotes HER2 internalization and sensitivity to trastuzumab-based therapy in HER2-positive breast cancers.
Baldassarre T; Truesdell P; Craig AW
Breast Cancer Res; 2017 Oct; 19(1):110. PubMed ID: 28974266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
